Cargando…

60: The real-world effectiveness of U.S. CF newborn screening

Detalles Bibliográficos
Autores principales:	Rosenfeld, M., Ostrenga, J., Cromwell, E., Fink, A., Szczesniak, R., Magaret, A., Sanders, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2021
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518473/ http://dx.doi.org/10.1016/S1569-1993(21)01485-5

Ejemplares similares

Processing Newborn Bloodspot Screening Results for CF
por: Barben, Jürg, et al.
Publicado: (2020)

281. Prevalence of Influenza Co-infection in a Real-world Cohort of COVID-19 Patients in the U.S
por: Chawla, Devika, et al.
Publicado: (2021)

Newborn Screening for CF across the Globe—Where Is It Worthwhile?
por: Scotet, Virginie, et al.
Publicado: (2020)

Current Practices for U.S. Newborn Screening of Pompe Disease and MPSI
por: Ames, Elizabeth G., et al.
Publicado: (2020)

492: CF innate immune defect affects CF intestinal microbiota
por: Scull, C., et al.
Publicado: (2021)

Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
por: Kellar-Guenther, Yvonne, et al.
Publicado: (2020)

239: Perspectives of people with CF and caregivers regarding medication access and telehealth in CF care during the COVID-19 pandemic
por: Phan, H., et al.
Publicado: (2021)

P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS
por: Mehta, Priyanka, et al.
Publicado: (2023)

P541: REAL-WORLD USE OF VENETOCLAX (VEN) IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) IN A US REAL-WORLD EVIDENCE DATABASE (COTA)
por: Zeidan, Amer M., et al.
Publicado: (2023)

524. COVID 19 Infection in Pregnant Women and Newborn Infants at a Single U.S. Center: What Disparities, Testing and Isolation Practices can Teach Us
por: Camelo, ingrid Y, et al.
Publicado: (2020)

Evaluating Real-World National and Regional Trends in Definitive Closure in U.S. Burn Care: A Survey of U.S. Burn Centers
por: Carter, Jeffrey E, et al.
Publicado: (2021)

USE OF FDA-APPROVED ALZHEIMER’S DISEASE MEDICATIONS AMONG NON-INSTITUTIONALIZED U.S. ADULTS AGE 60 YEARS AND OLDER
por: Frenk, Steven, et al.
Publicado: (2019)

P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING
por: Garg, Mahek, et al.
Publicado: (2023)

The Progress and Future of US Newborn Screening
por: Watson, Michael S., et al.
Publicado: (2022)

83: CF Global Care: Continuation of the collaboration between 2 CF centers; University of Michigan, USA, and Marmara University, Istanbul, Turkey, in the COVID-19 pandemic
por: Nasr, S., et al.
Publicado: (2021)

PROBLEM SOLVING SKILLS AND CANCER SCREENING BEHAVIORS IN MIDDLE-AGED AND OLDER MEN IN THE U.S.
por: Sahoo, Shalini, et al.
Publicado: (2019)

Real-World Evidence in Prescription Medication Use Among U.S. Adults with Neck Pain
por: Huang, Jin-Feng, et al.
Publicado: (2020)

288: COVID19 presented challenges: The CF legal information hotline delivered solutions
por: Sufian, B., et al.
Publicado: (2021)

59: The essential role of the community health worker in rural CF clinics
por: Yuen, N., et al.
Publicado: (2021)

P572: REAL-WORLD MANAGEMENT AND OUTCOMES FOR NEWLY DIAGNOSED AML PATIENTS INITIATING VENETOCLAX AND HYPOMETHYLATING AGENTS IN US COMMUNITY PRACTICE
por: Wang, Yuexi, et al.
Publicado: (2023)

A175 REAL-WORLD EXPERIENCE ON SWITCHING FROM ADALIMUMAB TO BIOSIMILARS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – AN OBSERVATIONAL STUDY FROM THREE TERTIARY CARE CENTRES
por: Bedi, H, et al.
Publicado: (2023)

PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.
por: Fonseca, R., et al.
Publicado: (2022)

P188 Vitamin D status at Bristol Adult CF Centre (BACFC) during the COVID-19 pandemic and following the introduction of the multivitamin Paravit CF
por: Keele, A., et al.
Publicado: (2022)

Accuracy of real-time multi-model ensemble forecasts for seasonal influenza in the U.S.
por: Reich, Nicholas G., et al.
Publicado: (2019)

The Obesity Paradox in Real-World Nation-Wide Cohort of Patients Admitted for a Stroke in the U.S.
por: Rozen, Guy, et al.
Publicado: (2022)

Racial disparities in access to DBS: results of a real-world U.S. claims data analysis
por: Frassica, Michael, et al.
Publicado: (2023)

515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF
por: Nakano, S., et al.
Publicado: (2021)

Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study
por: Schlüter, Daniela K, et al.
Publicado: (2020)

496: Reduced susceptibility of mice with CF-like lung disease to SARS-CoV-2 infection
por: Hawkins, P., et al.
Publicado: (2021)

14. A Comprehensive Real-World Analysis to Compare Adjuvanted Trivalent Influenza Vaccine and Trivalent High Dose Influenza Vaccine by Age and Period of High Influenza Activity for the 2018–19 Season among U.S. Elderly
por: Postma, Maarten, et al.
Publicado: (2020)

416: Expression of SARS-CoV-2 entry genes is not greater in the nasal mucosa of CF patients
por: Sala, M., et al.
Publicado: (2021)

113: Addressing food insecurity among patients with CF during the COVID-19 pandemic
por: Sewell, W., et al.
Publicado: (2021)

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
por: Oglesby, Alan, et al.
Publicado: (2021)

762. Real-World Utilization of C. difficile Drug Treatments and Associated Clinical Outcomes in a US Hospital System
por: McDaniel, Lauren, et al.
Publicado: (2021)

Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial–Eligible Populations
por: Dayal, Parul, et al.
Publicado: (2021)

P114: NEWBORN SCREENING FOR HAEMOGLOBINOPATHIES IN BIDA, NORTH CENTRAL NIGERIA.
por: Folayan, O, et al.
Publicado: (2022)

P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE
por: Harrison, C., et al.
Publicado: (2022)

Immunological Findings and Clinical Outcomes of Infants With Positive Newborn Screening for Severe Combined Immunodeficiency From a Tertiary Care Center in the U.S.
por: Mantravadi, Vasudha, et al.
Publicado: (2021)

Food Insecurity and Dental Caries in U.S. and South Korean Older Adults Ages 60+
por: Chi, Donald, et al.
Publicado: (2020)

86 Identifying Knowledge Gaps Using Adapted CF R.I.S.E in a Low Resource Setting
por: Gökdemir, Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_redeh7i90tgqi3ngft02kschsh